What to know about Johnson & Johnson vaccine pause


Martin Vu, Co-Editor-in-Chief

FOND DU LAC, Wis. (Sabre Voice) – It is common knowledge that mistakes are bound to happen, and the recent Johnson & Johnson mistake is not overlooked. As of Tuesday, April 13th, the Johnson & Johnson COVID vaccine has been put on pause. However, it is also common knowledge that misinformation and lack of information can lead to overthinking and panic. This Johnson & Johnson case, again, is no exception. 

 Nearly 7 million doses of their vaccine have been given in the U.S since the end of February. Yet only six people have reported the rare blood clot after getting the Johnson & Johnson shot. The blood clot, called a cerebral venous sinus thrombosis that forms in the brain’s venous sinuses, was seen with low platelet counts in the patients, according to a statement from  the Centers for Disease Control, or CDC, and Food and Drug Administration, or FDA.  

The CDC, said all cases are women between the ages 18 and 48 with symptoms occurring 6 to 13 days after receiving the vaccination. There are also reports of a 59-year-old woman who “developed deep vein thrombosis” after the vaccine and of a 25-year-old man who developed the clots during the trial, according to NBC News. On Wednesday, the CDC made the decision to extend the pause until they could view more data and determine the risk and treatment for the clots.

Although being prepared and alarmed is always good, panicking cause more trouble. It is important to remember only 6 of 6.8 million people have reported this rare blood clot, and the blood clot can be treated.  

However, the treatment is also part of the blood clot’s rarity. The blood clots caused by the Johnson & Johnson shot have to be treated differently than the regular blood clots. Nevertheless, if health care providers know which shot an individual has ahead of time, correct treatment can be provided, according to the CDC. In a statement from the CDA and FDA, recommended that doctors don’t give the drug Heparin, which is usually given when someone has a clot. The combination of the clot, along with low blood platelets can make using the drug dangerous, they said.  

The CDC advises anyone who received the Johnson & Johnson vaccination shot and is experiencing severe headaches, abdominal pain, leg pain, or shortness of breath within three weeks after the shot should contact their health care providers.

As of early April, nearly 70 million vaccination shots have been provided in the United States. While we are learning more and more about the vaccines and the virus each day, being informed and doing research is an important factor in preventing more panic.